Coexistence of BCR/ABL1-positive chronic myeloid leukemia and JAK2 V617F-mutated myelofibrosis successfully treated with dasatinib and ruxolitinib
- Author:
Jun Ho YI
1
;
Hye Ryoun KIM
Author Information
- Publication Type:Brief Communication
- MeSH: Dasatinib; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Primary Myelofibrosis
- From:Blood Research 2019;54(1):77-79
- CountryRepublic of Korea
- Language:English
- Abstract: No abstract available.
